Noble Wealth Partners LLC’s Biogen BIIB Stock Holding History

Noble Wealth Partners LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	+1,340	New	+$256K	0.25%	62

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Noble Wealth Partners LLC's BIIB Position: Q2 2026 in Review

Noble Wealth Partners LLC opened a new position in Biogen (BIIB) in Q2 2026: 1,340 shares worth $290K. The stake represents 0.25% of the portfolio and ranks #62 among its holdings.

269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Noble Wealth Partners LLC held 1,340 shares of Biogen worth $290K as of Q2 2026.
Biogen was a new Noble Wealth Partners LLC position in Q2 2026.
Biogen made up 0.25% of Noble Wealth Partners LLC's portfolio in Q2 2026, its #62 holding.
269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Noble Wealth Partners LLC's 13F filing for Q2 2026, filed 24 Jul 2026.